Cite
HARVARD Citation
Hampp, C. et al. (2017). Pioglitazone and bladder cancer: FDA's assessment. Pharmacoepidemiology and drug safety. 26 (2), pp. 117-118. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hampp, C. et al. (2017). Pioglitazone and bladder cancer: FDA's assessment. Pharmacoepidemiology and drug safety. 26 (2), pp. 117-118. [Online].